XML 106 R88.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT - USD ($)
Class A Common Stock
Motive Capital
Common Stock
Class B Common Stock
Motive Capital
Common Stock
Convertible preferred stock
Motive Capital
Additional Paid-in Capital
Motive Capital
Accumulated Deficit
Motive Capital
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at the beginning at Dec. 31, 2019             $ 0 [1] $ 2,785,000 $ (50,348,000) $ (47,563,000)
Balance at beginning (in shares) at Dec. 31, 2019             13,635,614      
Net income (loss)                 (9,712,000) (9,712,000)
Issuance of Class AA common stock upon exercise of vested stock options               21,000   21,000
Issuance of Class AA common stock upon early exercise of unvested stock options (in shares)             20,500      
Repurchase of early exercised stock options (in shares)             287,278      
Issuance of Class AA common stock in connection with Shares Post acquisition               44,817,000   44,817,000
Issuance of Class AA common stock in connection with Shares Post acquisition (in shares)             (13,915)      
Issuance of convertible preferred stock (in shares)             (9,015,140)      
Issuance of Junior convertible preferred stock in connection with Shares Post acquisition (Shares)     2,313,623              
Vesting of early exercised stock options               32,000   32,000
Share-based compensation expense               4,906,000   4,906,000
Balance at the end at Dec. 31, 2020   $ 1,035     $ (53,093,056) $ (53,092,021)   52,561,000 (60,060,000) (7,499,000)
Balance at ending (in shares) at Dec. 31, 2020   10,350,000         22,773,377      
Balance at the beginning at Sep. 27, 2020 $ 0 $ 0   $ 0 0 0        
Balance at beginning (in shares) at Sep. 27, 2020 0 0                
Net income (loss)         (11,799,629) (11,799,629)        
Issuance of Class B ordinary shares to Sponsor   $ 1,035   23,965   25,000        
Issuance of Class B ordinary shares to Sponsor (in shares)   10,350,000                
Cash received in Private Placement in excess of initial fair value of Private Placement warrants       (664,800)   (664,800)        
Accretion of Class A ordinary shares subject to possible redemption amount       $ (688,765) (41,293,427) (41,982,192)        
Balance at the end at Dec. 31, 2020   $ 1,035     (53,093,056) (53,092,021)   52,561,000 (60,060,000) (7,499,000)
Balance at ending (in shares) at Dec. 31, 2020   10,350,000         22,773,377      
Net income (loss)         9,363,744 9,363,744     (18,499,000) (18,499,000)
Issuance of Class AA common stock upon early exercise of unvested stock options               704,000   704,000
Issuance of Class AA common stock upon early exercise of unvested stock options (in shares)             413,172      
Repurchase of early exercised stock options (in shares)             834,064      
Issuance of Class AA common stock in connection with Shares Post acquisition (in shares)             (3,736,873)      
Issuance of convertible preferred stock               (39,722,000)   (39,722,000)
Issuance of Series B-1 convertible preferred stock at $8.69 per share upon conversion of convertible notes and accrued interest (Shares)     4,072,904              
Vesting of early exercised stock options               145,000   145,000
Share-based compensation expense               12,231,000   12,231,000
Balance at the end at Dec. 31, 2021   $ 1,035     $ (43,729,312) $ (43,728,277)   $ 25,919,000 $ (78,559,000) $ (52,640,000)
Balance at ending (in shares) at Dec. 31, 2021   10,350,000         20,269,864      
[1] amount less than 1